Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03618849 · ClinicalTrials.gov registry record · NA
tDCS in Pediatric Acquired Brain Injury
A NA study, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03618849 is a NA study that was terminated before completion, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 1 participants.
The verdict
NCT03618849, a NA study, was terminated before completion, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
In this preliminary study, we will examine the safety, tolerability, and feasibility of transcranial direct current stimulation (tDCS), in the setting of dosage escalation, as a candidate intervention for children with Acquired Brain Injury (ABI).
Interventions
- DEVICE tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2024-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03618849
The ClinicalTrials.gov registry entry for NCT03618849 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tDCS is the first listed.
NCT03618849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03618849 about?
NCT03618849 is a clinical study titled "tDCS in Pediatric Acquired Brain Injury". In this preliminary study, we will examine the safety, tolerability, and feasibility of transcranial direct current stimulation (tDCS), in the setting of dosage escalation, as a candidate intervention for children with Acquired Brain Injury (ABI).
What is the current status of trial NCT03618849?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-08-01. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT03618849?
The interventions under investigation include: tDCS (DEVICE).
Who is sponsoring clinical trial NCT03618849?
This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.